Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone.
Harari S, Caminati A, Confalonieri M, Poletti V, Vancheri C, Pesci A, Rogliani P, Luppi F, Agostini C, Rottoli P, Sanduzzi Zamparelli A, Sebastiani A, Della Porta R, Salton F, Messore B, Tomassetti S, Rosso R, Biffi A, Puxeddu E, Cerri S, Cinetto F, Refini RM, Bocchino M, Di Michele L, Specchia C, Albera C; ILDINET (Interstitial Lung Diseases Italian Network). Harari S, et al. Among authors: albera c. Clin Respir J. 2019 Mar;13(3):166-173. doi: 10.1111/crj.12999. Clin Respir J. 2019. PMID: 30675755 Free article.
First report of the Italian register for diffuse infiltrative lung disorders (RIPID).
Agostini C, Albera C, Bariffi F, De Palma M, Harari S, Lusuardi M, Pesci A, Poletti V, Richeldi L, Rizzato G, Rossi A, Schiavina M, Semenzato G, Tinelli C; Registro Italiano Pneumopatie Infiltrative Diffuse. Agostini C, et al. Among authors: albera c. Monaldi Arch Chest Dis. 2001 Aug;56(4):364-8. Monaldi Arch Chest Dis. 2001. PMID: 11770220 Free article.
Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.
du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, King TE Jr. du Bois RM, et al. Among authors: albera c. Am J Respir Crit Care Med. 2011 May 1;183(9):1231-7. doi: 10.1164/rccm.201007-1179OC. Epub 2010 Dec 3. Am J Respir Crit Care Med. 2011. PMID: 21131468 Free article. Clinical Trial.
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE Jr, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM; CAPACITY Study Group. Noble PW, et al. Among authors: albera c. Lancet. 2011 May 21;377(9779):1760-9. doi: 10.1016/S0140-6736(11)60405-4. Epub 2011 May 13. Lancet. 2011. PMID: 21571362 Clinical Trial.
Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.
du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Raghu G, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, King TE Jr. du Bois RM, et al. Among authors: albera c. Am J Respir Crit Care Med. 2011 Aug 15;184(4):459-66. doi: 10.1164/rccm.201011-1790OC. Am J Respir Crit Care Med. 2011. PMID: 21616999 Free article.
Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference.
du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, King TE Jr, Lancaster L, Noble PW, Sahn SA, Thomeer M, Valeyre D, Wells AU. du Bois RM, et al. Among authors: albera c. Am J Respir Crit Care Med. 2011 Dec 15;184(12):1382-9. doi: 10.1164/rccm.201105-0840OC. Epub 2011 Sep 22. Am J Respir Crit Care Med. 2011. PMID: 21940789 Free article.
Where do we stand with IPF treatment?
Albera C, Ferrero C, Rindone E, Zanotto S, Rizza E. Albera C, et al. Respir Res. 2013;14 Suppl 1(Suppl 1):S7. doi: 10.1186/1465-9921-14-S1-S7. Epub 2013 Apr 16. Respir Res. 2013. PMID: 23734956 Free PMC article.
116 results